Cargando…

Total Protein–Chloride Ratio in Pleural Fluid Independently Predicts Overall Survival in Malignant Pleural Effusion at the First Diagnosis

OBJECTIVE: Pre-treatment biomarkers to estimate overall survival (OS) for malignant pleural effusion (MPE) are unidentified, especially those in pleural fluid. We evaluated the relationship between OS and total protein–chloride ratio in malignant pleural effusion (PE TPClR). MATERIALS AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Xin, Zhang, Zhi-Rong, Shi, Xin-Yu, Yi, Feng-Shuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786110/ https://www.ncbi.nlm.nih.gov/pubmed/35083140 http://dx.doi.org/10.3389/fonc.2021.777930

Ejemplares similares

Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion
por: Hackner, Klaus, et al.
Publicado: (2019)

Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio)
por: Verma, Akash, et al.
Publicado: (2015)

The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
por: Santotoribio, Jose D., et al.
Publicado: (2019)

Pleural Fluid Resolution Is Associated with Improved Survival in Patients with Malignant Pleural Effusion
por: MacRosty, Christina R., et al.
Publicado: (2023)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Age : pleural fluid ADA ratio and other indicators for differentiating between tubercular and malignant pleural effusions
por: Zhou, Jiupeng, et al.
Publicado: (2022)

Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
por: Sorolla, Maria Alba, et al.
Publicado: (2021)

Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival
por: Wu, Cheng-Guang, et al.
Publicado: (2022)

Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion
por: Shi, Xin‐Yu, et al.
Publicado: (2019)

Malignant pleural effusion: Updates in diagnosis, management and current challenges
por: Addala, Dinesh Narayan, et al.
Publicado: (2022)

Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods
por: Darooei, Reza, et al.
Publicado: (2017)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion
por: Lin, Liyan, et al.
Publicado: (2021)

Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

Diagnostic accuracy of pleural fluid to serum carcinoembryonic antigen ratio and delta value for malignant pleural effusion: findings from two cohorts
por: Jiang, Meng-Ping, et al.
Publicado: (2023)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
por: Korczynski, P, et al.
Publicado: (2009)

Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)

Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion
por: Huang, Jin-Hong, et al.
Publicado: (2023)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model
por: Zhang, Xin, et al.
Publicado: (2021)

Pleural Fluid Cholesterol in Differentiating Exudative and Transudative Pleural Effusion
por: Hamal, A. B., et al.
Publicado: (2013)

Pleural Fluid Pentraxin-3 for the Differential Diagnosis of Pleural Effusions
por: Yeo, Chang Dong, et al.
Publicado: (2013)

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
por: JI, QIAOYING, et al.
Publicado: (2014)

The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study
por: Wu, Huimin, et al.
Publicado: (2017)

Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study
por: Pairman, Lorna, et al.
Publicado: (2022)

Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
por: Verma, Akash, et al.
Publicado: (2016)

Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
por: Principe, Nicola, et al.
Publicado: (2021)

A detection panel of novel methylated DNA markers for malignant pleural effusion
por: Liang, Chaonan, et al.
Publicado: (2022)

Diagnostic accuracy of pleural fluid lactate dehydrogenase to adenosine deaminase ratio for tuberculous pleural effusion: an analysis of two cohorts
por: Yan, Zhi, et al.
Publicado: (2022)

Comparative Analysis of Mean Pleural Fluid D-dimer Level in Malignant and Non-Malignant Pleural Effusion Patients
por: Emami Ardestani, Mohammad, et al.
Publicado: (2019)

The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions
por: Wang, Jinlin, et al.
Publicado: (2017)

Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion
por: Rabbi, Mohammad Fazle, et al.
Publicado: (2023)

Implantation of permanent pleural catheter for palliation of malignant pleural effusion
por: Meier, Michelle, et al.
Publicado: (2016)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
por: Báez-Saldaña, Renata, et al.
Publicado: (2017)

Indwelling pleural catheters for malignant pleural effusion – Are we ready?
por: Patel, Dharmesh, et al.
Publicado: (2022)

Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
por: Li, Xin, et al.
Publicado: (2022)

Long‐term stability of pleural fluid carcinoembryonic antigen and its effect on the diagnostic accuracy for malignant pleural effusion
por: Yang, Dan‐Ni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gibe32tpgpchlh7rlpedf1l4mc